Twist Bioscience Target Price

Analysts' average 12-month price target for Twist Bioscience is $92.

Get informed when a big investor buys or sells

+ Follow

Share Price

$116.1

Average Target Price

$92.47

20.4% downside

15 analysts in the last 4 months

High: $120 | Low: $60

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-05	Piper Sandler	$115	0.9% downside
2026-08-04	Robert W. Baird	$115	0.9% downside
2026-07-16	Leerink PartnersPuneet Souda	$110	5.3% downside
2026-07-14	Canaccord GenuityKyle Mikson	$120	3.4% upside
2026-07-06	Evercore ISI	$102	12.1% downside
2026-06-29	Guggenheim	$107	7.8% downside
2026-06-24	BarclaysLuke Sergott	$95	18.2% downside
2026-06-15	Cowen & Co.	$89	23.3% downside
2026-06-15	Canaccord Genuity	$90	22.5% downside
2026-06-15	UBS	$89	23.3% downside
2026-06-11	Piper SandlerDavid Westenberg	$85	26.8% downside
2026-05-22	Leerink PartnersPuneet Souda	$80	31.1% downside
2026-05-05	GuggenheimSubbu Nambi	$60	48.3% downside
2026-05-05	Robert W. BairdCatherine Ramsey Schulte	$65	44% downside
2026-05-04	Barclays	$65	44% downside
2026-04-14	BarclaysLuke Sergott	$55	52.6% downside
2026-02-03	Robert W. Baird	$50	56.9% downside
2026-02-03	Evercore ISI	$52	55.2% downside
2026-02-03	Barclays	$50	56.9% downside
2026-01-05	Evercore ISI	$42	63.8% downside
2025-12-15	Barclays	$39	66.4% downside
2025-11-03	StephensSteven Etoch	$41	64.7% downside
2025-10-02	Barclays	$40	65.5% downside
2025-08-04	Evercore ISI	$46	60.4% downside
2025-05-06	Robert W. BairdCatherine Ramsey Schulte	$44	62.1% downside
2025-03-28	Guggenheim	$50	56.9% downside
2025-02-04	Robert W. BairdCatherine Ramsey Schulte	$54	53.5% downside
2025-02-03	BarclaysLuke Sergott	$58	50% downside
2024-09-17	Robert W. BairdCatherine Schulte	$46	60.4% downside
2024-06-05	GuggenheimSubbu Nambi	$53	54.3% downside
2024-05-03	Robert W. BairdCatherine Ramsey Schulte	$40	65.5% downside
2024-01-17	Goldman SachsMatthew Sykes	$45	61.2% downside
2023-02-05	BarclaysLuke Sergott	$32	72.4% downside
2023-01-03	Evercore ISI	$36	69% downside
2022-10-06	BarclaysLuke Sergott	$45	61.2% downside

Twist Bioscience (TWST) FAQ

Twist Bioscience (TWST) currently reports a target price of $92. Use the charts on this page to explore Twist Bioscience's target price history and peer comparisons.

Analysts' average 12-month price target for Twist Bioscience is $92, about 20.4% downside from the current share price of $116.1. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $92, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Twist Bioscience, and consider following TWST for alerts when major investors trade the stock.

Twist Bioscience is classified in the Healthcare sector. On target price, it currently shows $92. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TWST with unrelated industries.